C21 Investments

The cannabis sector has seen its share of turbulence, highlighted by a 15.24% drop in the MSOS ETF (NYSE:MSOS) following the DEA’s decision to delay the rescheduling of cannabis until December 2nd. This delay adds to the uncertainty in an already volatile market, particularly as the U.S....

C21 Investments (OTC: CXXI) and Vext Science (OTC: VEXT) have demonstrated notable financial performance, particularly in cash flow and credit stability. This is significant given the challenges faced by many larger cannabis companies. Despite market caps of $29.98 million for Vext and $33.33...

Here is a summary of the latest leadership changes within the cannabis industry. Papa & Barkley Announces Promotions, New Hires Cannabis wellness company Papa & Barkley has boosted its executive team with several promotions and new hires. Adam Grossman, who served as founder and CEO of...

Body And Mind Q4 Revenue Increases By 106% Sequentially Cannabis company Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) announced fiscal results for the fourth quarter and fiscal year ending July 31. The Vancouver-based company generated $6.23 million in consolidated revenue for the whole year...

Cannabis company C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) has qualified to begin trading on the OTCQX, under the symbol CXXIF. OTC Markets Group Inc. (OTCQX: OTCM) confirmed the news Monday. Previously, New York-based C21 traded on the OTCQB Venture Market....